Search Results 41-50 of 16626 for Certolizumab

  1. Adalimumab (subcutaneous route) - Side effects & dosage - Mayo Clinic

    Baricitinib; Certolizumab Pegol; Cholera Vaccine, Live; Cyclosporine; Dengue Tetravalent Vaccine, Live; Ebola Zaire Vaccine, Live; Etanercept; Golimumab ...

  2. Hematology - Clinical trials

    The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...

  3. Inflammatory bowel disease (IBD) - Diagnosis and treatment - Mayo Clinic

    Examples include infliximab (Remicade), adalimumab (Humira), golimumab (Simponi), certolizumab (Cimzia), vedolizumab (Entyvio), ustekinumab (Stelara) and ...

  4. Zoster vaccine, live (subcutaneous route) - Side effects & uses - Mayo Clinic

    Baricitinib; Belatacept; Betibeglogene Autotemcel; Bimekizumab-bkzx; Brensocatib; Brodalumab; Canakinumab; Certolizumab Pegol; Cyclosporine; Deucravacitinib ...

  5. Ulcerative Colitis Clinical Trials

    ... certolizumab. However, many CD and UC patients still ultimately require surgery despite the use of these medications. Side effects of the anti-TNF agents ...

  6. Drugs and Supplements that Start with C - Mayo Clinic

    Certolizumab (subcutaneous route). Cerubidine. Also known as. Daunorubicin (intravenous route). Cervarix. Also known as. Human papillomavirus vaccine ...

  7. Hodgkin Clinical Trials - Mayo Clinic Research

    This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...

  8. Eculizumab (intravenous route) - Side effects & uses - Mayo Clinic

    Eculizumab injection is used to treat a type of blood disease called paroxysmal nocturnal hemoglobinuria (PNH). This medicine helps reduce red blood cell ...

  9. Tislelizumab-jsgr (intravenous route) - Side effects & uses - Mayo Clinic

    Your doctor will test for the presence of this tumor. This medicine is also used alone to treat ESCC that has spread of cannot be removed by surgery in patients ...

  10. Advances in the treatment of Crohn's disease and ulcerative colitis - Mayo Clinic

    Within the United States, four anti-TNF agents are currently approved for the treatment of IBD — infliximab, adalimumab, certolizumab pegol and golimumab.